Dr. Alan Bryce presented the preliminary results from a phase II trial of PT-112 monotherapy in late-line metastatic castration-resistant prostate cancer (mCRPC). Late-line mCRPC patients have poor ...

Very soon after the Big Bang, the universe enjoyed a brief phase where quarks and gluons roamed freely, not yet joined up ...

Protagenic Therapeutics (NASDAQ: PTIX) just pulled off a biotech plot twist worthy of a season finale. On May 19, shares ...

In this work, we report an innovative top-down strategy to prepare the supported Pt nanoparticles with an average size of ∼2 nm, starting directly from bulk metallic Pt by metallurgical method. Bulk ...

† Beijing Key Laboratory for Green Catalysis and Separation, Department of Chemistry and Chemical Engineering, Beijing University of Technology, Beijing 100124, PR China ‡ Key Lab of Theory and ...